These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1490 related items for PubMed ID: 25408407

  • 21. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R, Wei P, Yang J.
    Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
    [Abstract] [Full Text] [Related]

  • 22. CRISPR/Cas9 and TALEN-mediated knock-in approaches in zebrafish.
    Auer TO, Del Bene F.
    Methods; 2014 Sep; 69(2):142-50. PubMed ID: 24704174
    [Abstract] [Full Text] [Related]

  • 23. Expanding the Biologist's Toolkit with CRISPR-Cas9.
    Sternberg SH, Doudna JA.
    Mol Cell; 2015 May 21; 58(4):568-74. PubMed ID: 26000842
    [Abstract] [Full Text] [Related]

  • 24. CRISPR-Cas: From the Bacterial Adaptive Immune System to a Versatile Tool for Genome Engineering.
    Kirchner M, Schneider S.
    Angew Chem Int Ed Engl; 2015 Nov 09; 54(46):13508-14. PubMed ID: 26382836
    [Abstract] [Full Text] [Related]

  • 25. ssODN-mediated knock-in with CRISPR-Cas for large genomic regions in zygotes.
    Yoshimi K, Kunihiro Y, Kaneko T, Nagahora H, Voigt B, Mashimo T.
    Nat Commun; 2016 Jan 20; 7():10431. PubMed ID: 26786405
    [Abstract] [Full Text] [Related]

  • 26. The CRISPR/Cas9 system: Their delivery, in vivo and ex vivo applications and clinical development by startups.
    Song M.
    Biotechnol Prog; 2017 Jul 20; 33(4):1035-1045. PubMed ID: 28440027
    [Abstract] [Full Text] [Related]

  • 27. Dynamics of CRISPR-Cas9 genome interrogation in living cells.
    Knight SC, Xie L, Deng W, Guglielmi B, Witkowsky LB, Bosanac L, Zhang ET, El Beheiry M, Masson JB, Dahan M, Liu Z, Doudna JA, Tjian R.
    Science; 2015 Nov 13; 350(6262):823-6. PubMed ID: 26564855
    [Abstract] [Full Text] [Related]

  • 28. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
    Huo X, Du Y, Lu J, Guo M, Li Z, Zhang S, Li X, Chen Z, Du X.
    Mutat Res; 2017 Mar 13; 797-799():1-6. PubMed ID: 28284774
    [Abstract] [Full Text] [Related]

  • 29. High-throughput screens in mammalian cells using the CRISPR-Cas9 system.
    Peng J, Zhou Y, Zhu S, Wei W.
    FEBS J; 2015 Jun 13; 282(11):2089-96. PubMed ID: 25731961
    [Abstract] [Full Text] [Related]

  • 30. Connecting genotypes, phenotypes and fitness: harnessing the power of CRISPR/Cas9 genome editing.
    Bono JM, Olesnicky EC, Matzkin LM.
    Mol Ecol; 2015 Aug 13; 24(15):3810-22. PubMed ID: 26033315
    [Abstract] [Full Text] [Related]

  • 31. The Smart Programmable CRISPR Technology: A Next Generation Genome Editing Tool for Investigators.
    Chakraborty C, Teoh SL, Das S.
    Curr Drug Targets; 2017 Aug 13; 18(14):1653-1663. PubMed ID: 27231109
    [Abstract] [Full Text] [Related]

  • 32. Genetic screens and functional genomics using CRISPR/Cas9 technology.
    Hartenian E, Doench JG.
    FEBS J; 2015 Apr 13; 282(8):1383-93. PubMed ID: 25728500
    [Abstract] [Full Text] [Related]

  • 33. Cas9 specifies functional viral targets during CRISPR-Cas adaptation.
    Heler R, Samai P, Modell JW, Weiner C, Goldberg GW, Bikard D, Marraffini LA.
    Nature; 2015 Mar 12; 519(7542):199-202. PubMed ID: 25707807
    [Abstract] [Full Text] [Related]

  • 34. CRISPR: gene editing is just the beginning.
    Ledford H.
    Nature; 2016 Mar 10; 531(7593):156-9. PubMed ID: 26961639
    [No Abstract] [Full Text] [Related]

  • 35. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.
    Kleinstiver BP, Pattanayak V, Prew MS, Tsai SQ, Nguyen NT, Zheng Z, Joung JK.
    Nature; 2016 Jan 28; 529(7587):490-5. PubMed ID: 26735016
    [Abstract] [Full Text] [Related]

  • 36. Genome editing: The domestication of Cas9.
    Urnov F.
    Nature; 2016 Jan 28; 529(7587):468-9. PubMed ID: 26819037
    [No Abstract] [Full Text] [Related]

  • 37. Production of knockout mice by DNA microinjection of various CRISPR/Cas9 vectors into freeze-thawed fertilized oocytes.
    Nakagawa Y, Sakuma T, Sakamoto T, Ohmuraya M, Nakagata N, Yamamoto T.
    BMC Biotechnol; 2015 May 22; 15():33. PubMed ID: 25997509
    [Abstract] [Full Text] [Related]

  • 38. All-in-One CRISPR-Cas9/FokI-dCas9 Vector-Mediated Multiplex Genome Engineering in Cultured Cells.
    Sakuma T, Sakamoto T, Yamamoto T.
    Methods Mol Biol; 2017 May 22; 1498():41-56. PubMed ID: 27709568
    [Abstract] [Full Text] [Related]

  • 39. CRISPR/Cas9 Immune System as a Tool for Genome Engineering.
    Hryhorowicz M, Lipiński D, Zeyland J, Słomski R.
    Arch Immunol Ther Exp (Warsz); 2017 Jun 22; 65(3):233-240. PubMed ID: 27699445
    [Abstract] [Full Text] [Related]

  • 40. Cas9-based genome editing in Drosophila.
    Housden BE, Lin S, Perrimon N.
    Methods Enzymol; 2014 Jun 22; 546():415-39. PubMed ID: 25398351
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 75.